Russia’s RDIF says it has struck deals to make Sputnik V vaccine in 4 EU Countries


MOSCOW, March 9 (Reuters) – The head of Russia’s RDIF sovereign wealth fund said on Tuesday that his organisation had struck deals with production facilities in Italy, Spain, France and Germany to manufacture the Sputnik V vaccine against COVID-19.

Speaking to state channel Rossiya 24, Kirill Dmitriev, RDIF’s head, did not provide any details.

He was speaking after RDIF signed a commercial deal with a Swiss-based pharmaceuticals company to produce the vaccine in Italy.

(Reporting by Polina Nikolskaya and Gabrielle Tétrault-Farber Editing by Andrew Osborn)

Discover more from The Dispatch

Subscribe now to keep reading and get access to the full archive.

Continue reading

Verified by MonsterInsights